Zocere Inc. in Albuquerque, New Mexico is licensing a neurological protein from University of New Mexico for development into a drug to protect ischemic stroke victims from extensive brain damage. #Science#Business
For #ScienceSunday this week, we offer the findings from University of Pennsylvania, Albert Einstein College of Medicine, and the biotechnology company Sangamo BioSciences that showed the company’s gene-editing technology could engineer the immune cells of HIV-positive patients to resist infection and decrease their viral loads.
Biomedical engineers at Harvard University proposed a scheme for assessing the quality of stem cells used in drug testing to assure they transform into the cells and tissue they purport to represent. #Science#Business
Researchers from University of Pennsylvania, Albert Einstein College of Medicine, and the biotechnology company Sangamo BioSciences showed the company’s gene-editing technology could engineer the immune cells of HIV-positive patients to resist infection and decrease their viral loads. #Science#Business
An intermediate-stage clinical trial by La Jolla Pharmaceutical Company in San Diego shows patients with chronic kidney disease taking the company’s drug candidate succeeded in improving their kidney functions, compared to similar patients taking a placebo. #Science#Business
LionsGate Technologies, a medical device developer in Vancouver, British Columbia, received $2 million in private and public financing for its smartphone app measuring blood oxygen levels in pregnant women. #Science#Business
University of Nevada in Reno and NevadaNano, a spin-off company from the university, are developing an aerial robotic device for environmental sensing and reporting over a large area. #Science#Business
Life science and engineering researchers at Harvard University developed a sponge-like gel material that when seeded with embryonic cells in lab tests shrinks and hardens into a predecessor of human tooth tissue. #Science#Business
Writer, editor, publisher, photographer, and runner ... in no particular order
Alan Kotok is a Washington, DC-based reporter and
writer on technology, business, and public policy,
and editor and publisher of Science & Enterprise, an online news service on the value
chain connecting scientific discovery with the
Wrote three print and two e-books books, started two companies, ran two marathons
MSc, Public Communications, 1967 - 1969
University of Iowa
Journalism, 1963 - 1967
We were unable to fetch any YouTube videos at this time. Please try again.
Videos are visible only to people they've been shared with.
We were unable to fetch any videos at this time. Please try again.